(Q38413090)

2 September 2017

Thrombin expression in prostate: a novel finding (English)

1 reference

2 September 2017

0 references

Manish Kohli

1

1 reference

2 September 2017

Karin Williams

2

1 reference

2 September 2017

Jorge L Yao

3

1 reference

2 September 2017

Richard A Dennis

4

1 reference

2 September 2017

Jiaoti Huang

5

1 reference

2 September 2017

Jay Reeder

6

1 reference

2 September 2017

William A Ricke

7

1 reference

2 September 2017

1 January 2011

1 reference

2 September 2017

1 reference

2 September 2017

29

1 reference

2 September 2017

1

1 reference

2 September 2017

62-67

1 reference

Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study

2 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Activation of the coagulation system in cancerogenesis and metastasation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Stromal factors involved in prostate carcinoma metastasis to bone

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Pathways of coagulation/fibrinolysis activation in malignancy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Thrombin causes a marked delay in skeletal myogenesis that correlates with the delayed expression of myogenin and p21CIP1/WAF1.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Thrombin receptor expression is upregulated in prostate cancer.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3136353

Prognosis of Cancers Associated with Venous Thromboembolism

31 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.3109%2F07357907.2010.535057

The MET oncogene drives a genetic programme linking cancer to haemostasis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3109%2F07357907.2010.535057

Fibrin formation on vessel walls in hyperplastic and malignant prostate tissue

21 January 2018

1 reference

12 December 2020

Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding

1 reference

12 December 2020

Thrombin receptor-dependent prostaglandin E2 synthesis in hamster fibroblasts: synergistic interactions with interleukin-1beta

1 reference

12 December 2020

Expression of tissue factor in prostate cancer correlates with malignant phenotype

1 reference

12 December 2020

Human Protease-Activated Receptor 1 Expression in Malignant Epithelia

1 reference

12 December 2020

10.3109/07357907.2010.535057

Identifiers

DOI

1 reference

2 September 2017

1 reference

2 September 2017

PubMed publication ID

21166500

1 reference